DEXCOM, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
DEXCOM, INC. (DXCM) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $6.34 per share for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2019-02-21
- DEXCOM, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2018 was $6.34, a 22.78% decline from fiscal 2017.
- DEXCOM, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2017 was $8.21, a 5.80% increase from fiscal 2016.
- DEXCOM, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2016 was $7.76, a 100.00% decline from fiscal 2015.
- DEXCOM, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2015 was $8220000.00, a 3.79% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2018-12-31 | $6.34 10-K · filed 2019-02-21 |
| 2017-12-31 | $8.21 10-K · filed 2018-02-27 |
| 2016-12-31 | $7.76 10-K · filed 2017-02-28 |
| 2015-12-31 | $8220000.00 10-K · filed 2016-02-23 |
| 2014-12-31 | $7920000.00 10-K · filed 2015-02-25 |
| 2013-12-31 | $6640000.00 10-K · filed 2014-02-20 |
| 2012-12-31 | $5.50 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |